Specialists for Wild type ATTR amyloidosis

9 physicians and care centers identified from ClinicalTrials.gov trial PIs, PubMed publications, and the NPPES NPI registry.

ℹ

Specialists are identified from ClinicalTrials.gov principal investigators, PubMed publications, and the NPI registry, then ranked through an automated scoring pipeline.

Report missing data

Mazen Hanna, MD, M.D
Rare Disease / Clinical Research
The Cleveland Clinic
CLEVELAND, OH
QC-verified PI×1
Adalgisa Condoluci, MD
Rare Disease / Clinical Research
Oncology Institute of Southern Switzerland
QC-verified PI×1 1
Mathew S Maurer, MD
Rare Disease / Clinical Research
Columbia University
PI×1
John L Berk, M.D., D.D.S
Rare Disease / Clinical Research
Boston University
CASTRO VALLEY, CA
PI×1
Nicolas Verheyen, Res Prof, MD PhD
Rare Disease / Clinical Research
Medical University of Graz
PI×1
Torstein Hole, MD, PhD
Rare Disease / Clinical Research
Helse Møre og Romsdal HF and NTNU
PI×1
Jeff Packman, MBA
Rare Disease / Clinical Research
FoldRx Pharmaceuticals, Inc
PI×1
MARK MCGOVERN, RN
Rare Disease / Clinical Research
Eidos Therapeutics, a BridgeBio company
PI×1
Thibaud DAMY, MD PhD
Rare Disease / Clinical Research
CHU Henri Mondor, Paris
PI×1

More about Wild type ATTR amyloidosis